Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Dr. Rath Health Foundation Newsletter

November 16, 2012

If you would like to receive our newsletters regularly, please send us an email.

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.


For more natural health news, click here.
See also our 2001-2011 news archive, by clicking here.

Vitamin D may prevent clogged arteries in diabetics

November 13, 2012

People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame.
Read article at medicalxpress.com

Vitamin D Could Hold Vital Key to Arresting Development of Alzheimer’s Disease

November 8, 2012

Scientists at London's Kingston University have uncovered evidence that lack of a particular form of vitamin D is associated with Alzheimer's disease.
Read article at sciencedaily.com

Antioxidants may ease PAD blood pressure increase

November 8, 2012

Low antioxidant levels contribute to increased blood pressure during exercise for people with peripheral arterial disease, according to researchers at Penn State Hershey Heart and Vascular Institute.
Read article at medicalxpress.com

Comment: This study found that, in severe cases of peripheral arterial disease, blood pressure increases more with exercise. However, by infusing vitamin C into the patients’ blood, the researchers were able to lessen the increase in blood pressure. To learn how high blood pressure can be normalized using vitamin C, magnesium, coenzyme Q-10, arginine and other essential micronutrients, click here.

Pycnogenol shows benefits for asthmatics: Study

November 7, 2012

Daily supplements of the French Maritime Pine bark extract Pynogenol may improve symptoms of asthma, according to results of a clinical trial.
Read article at nutraingredients.com


For more pharma "business with disease" news, click here.
See also our 2001-2011 news archive, by clicking here.

Babies given Calpol and other forms of paracetamol are more likely to develop asthma

November 12, 2012

Babies given Calpol and other forms of paracetamol are more likely to develop asthma before going to school, say Danish researchers.
Read article in the Daily Mail (UK)

Hundreds of Croatian doctors linked to corruption probe

November 12, 2012

Hundreds of doctors in Croatia have been implicated in a corruption probe targeting a local pharmaceutical firm whose management and other workers were detained Monday, a minister said.
Read AFP news report at yahoo.com

US lawsuit extends thalidomide's reach
Drug blamed for a broader range of harmful effects.

November 8, 2012

In a new twist of a historic tragedy, 13 Americans who say they are survivors of thalidomide are suing four companies for producing and distributing the notorious drug. They say that the drug — used by pregnant women for morning sickness until it was discovered to cause severe birth defects — affected more people in the United States than thought, and caused a wider range of deformities. And, they say, the companies have done all they can to hide these facts.
Read article at nature.com


For more GMO news, click here.
See also our 2001-2011 news archive, by clicking here.

Study Confirms GM crops lead to increased Pesticide Use

November 8, 2012

A new peer-reviewed study has blown away the persistent claims made by agritech corporations that GM crops are beneficial to both the environment and human health by reducing pesticide use.
Read article on the Institute of Science in Society (ISIS) website (UK)

Could millions of GM insects be released into British crop fields without safety checks?

November 8, 2012

Millions of GM insects developed by British scientists could be released into food crop fields without proper safety checks, it is claimed.
Read article in the Daily Mail (UK)

Monsanto Meets Ministers to Push Return of GM Crops to Britain

October 25, 2012

GeneWatch UK and GM Freeze today released documents obtained as a result of a Freedom of Information request, which reveal that the GM companies Monsanto, Syngenta, Bayer and BASF are setting the agenda for UK agricultural research with a view to bringing GM crops into the UK and exporting overseas.
Read press release at gmfreeze.org (UK)


For more health-related news, click here.
See also our 2001-2011 news archive, by clicking here.

Lack of vitamin D contributes to pain in black Americans with knee osteoarthritis

November 7, 2012

A new study reveals that black Americans display lower levels of vitamin D and greater pain sensitivity compared to white Americans. Findings published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), indicate that vitamin D deficiency may be one of many factors that account for increased pain in older black Americans with knee osteoarthritis (OA).
Read article at medicalxpress.com

Pesticide Threat Looms Large Over Farmworker Families

October 20, 2012

No matter how good your next meal tastes, it's likely it made society ill. A new analysis by the Pesticide Action Network North America (PAN) draws a disturbing connection between pesticides in our food system and serious health problems among women and children. The report reviews empirical research linking agricultural chemicals to birth defects, neurological disorders, childhood cancers and reproductive problems.
Read article at inthesetimes.com


For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

Big Brother alert: Microsoft wants to know how many friends you've got in your living room

November 9, 2012

One of Microsoft’s latest patent applications is a humdinger. It proposes to turn the Kinect camera into a snitch for movie studios, reporting back just how many friends you’ve got in your living room and what they’re watching. Think that sounds alarmist? Here’s what it actually says: “The users consuming the content on a display device are monitored so that if the number of user-views licensed is exceeded, remedial action may be taken.” It’s that blatant – a system to spy on private viewing habits.
Read article in the Daily Telegraph (UK)

Commission gives a warm welcome to unregistered lobbyists: Dalli not alone in ignoring transparency

November 5, 2012

Ex-Commissioner John Dalli knowingly met with lobbyists who were not registered in the European Commission and European Parliament’s Transparency Register. Lobbyists who choose to hide from the public who they're lobbying for, on what subject, or how much money they’re spending to influence public policy. Lobbyists who work in the shadows. Shocking? Yes, but it is a very common practice in the Commission to meet with unregistered lobbyists, a sure-fire indicator that despite what it says, the Commission is not really concerned about lobby transparency.
Read article on the Corporate Europe Observatory website

Israeli Report Cites a Thwarted 2010 Move on Iran

November 4, 2012

JERUSALEM — An Israeli news channel reported Sunday night that Prime Minister Benjamin Netanyahu and Defense Minister Ehud Barak asked the Israeli military in 2010 to prepare for an imminent attack on the Iranian nuclear program, but that their efforts were blocked by concerns over whether the military could do so and whether the men had the authority to give such an order.
Read article in the New York Times (USA)

Dalligate: Smokescreen or smoking gun?

October 25, 2012

Over the last week an increasingly unclear and fraught picture of a major European lobbying scandal has been unfolding. “Dalligate” or “snusgate” has been heralded as “the biggest tobacco industry interference in public health policy at the European level”, and led to the unprecedented resignation – or maybe dismissal - of Maltese Commissioner for Health and Consumer Policy, John Dalli. Given the Commission's normally relaxed attitude to industry lobbying, this was surprising. In fact, this is the first time a Commissioner has been removed over a lobby scandal. Unfortunately there's no reason to believe this is the start of a new, stricter approach. The Commission's messy handling of the case, characterised by improvisation rather than clear and transparent procedures, has raised more questions than it answers. The Commission must urgently end its secrecy around the Dalli case and publish all the facts from the OLAF investigation.
Read article on the Corporate Europe Observatory website


Back to the Newsletter Archive…